Home - Resources -Topicdrug pricing

June 2, 2026
Action Brief

Rebates and Retrospective Discounts in Pharmacy Benefit Management Summary

Most PBM contracts rely on rebates and other retrospective pricing mechanisms — including discounts, guarantees, and reconciliation processes that determine the final net cost of drugs — only after claims […]

April 17, 2026
Article

New Tools Tell the Story: 340B Is Raising Costs for Employers and Working Families

Illinois employers are feeling the strain of rising healthcare costs while trying to preserve benefits, support their workforce, and stay competitive. As costs continue to climb, employers are looking more […]

April 6, 2026
Article

MN Report Adds to the Evidence: 340B Growth is Bad for Business

The Minnesota Department of Health’s recent report and the National Alliance’s new Cost Calculator make it clear: 340B has a significant impact on Minnesota businesses and working families, and locking […]

March 24, 2026
Article

340B Growth: Bad for Business in New York

New York employers are under growing pressure from a healthcare system that keeps getting more expensive and harder to understand. The National Alliance offers insights into these dynamics, including the […]

November 7, 2025
Final Report

Ending the HIV Epidemic: Employer Strategies for Impact and Support

The National Alliance launched a four-part workshop series in 2025 to engage employer coalitions and human resources benefits leaders to accelerate progress towards ending America’s HIV epidemic. The workshops convened […]

November 5, 2025
Action Brief

Employers Beware: 340B Program Shared Savings Models Require Scrutiny

With drug spending a top concern for plan sponsors and costs rising, employers continue to explore new strategies to better manage spending. New “shared savings” vendors attempt to appeal to employers […]